Skip to main content
. 2020 Aug 3;11(3):748–787. doi: 10.1007/s13346-020-00818-0

Table 2.

Lipid-based nanoformulation

Diseases Antiviral drug Type of nanodelivery system Lipid/polymer used as carrier Key findings Ref
HIV Stavudine Gelatin liposomes Soya lecithin, gelatin

Improves targeting to a reservoir site

Controls residual viremia

[69]
VZV, diseases caused by herpes zoster, herpes simplex virus Acyclovir Solid lipid nanoparticles Compritol 888 ATO and soya lecithin Improve transdermal delivery [70]
Conjunctival, corneal, and intraocular infections and retinitis Acyclovir Solid lipid nanoparticles Stearic acid, Cithrol GMS, Compritol Improve ocular delivery [71]
HIV Efavirenz Solid lipid nanoparticles Glyceryl monostearate, Tween 80 Enhances solubility [72]
HIV Lopinavir SLN Stearic acid High LPV accumulation in lymphoidal organs [73].
HIV, herpes infection Acyclovir Nanostructured lipid carrier Compritol®888 ATO, Lauroglycol™ 90, Capryol™ 90, Tween® 40 Increased permeation [74]
HIV Indinavir Lipid nanoemulsion Cholesterol, Tween 80 Improved drug permeability [62]
HIV Saquinavir Nanoemulsion Lipoid®-80

Improved bioavailability

Higher amount of the drug was able to reach the brain

[61]
Herpes infection Acyclovir palmitate Reconstituted HDL acyclovir palmitate Phosphatidylcholin, sodium deoxycholate High liver targeting property [75]